{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:48:43Z","timestamp":1782820123173,"version":"3.54.5"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":942,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/pme.12016","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T16:06:41Z","timestamp":1356710801000},"page":"257-264","source":"Crossref","is-referenced-by-count":19,"title":["Zoledronate for Metastatic Bone Disease and Pain: A Meta-Analysis of Randomized Clinical Trials"],"prefix":"10.1093","volume":"14","author":[{"given":"Min","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"2016011923145449000_14.2.257.1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0931"},{"key":"2016011923145449000_14.2.257.2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G"},{"key":"2016011923145449000_14.2.257.3","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"2016011923145449000_14.2.257.4","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.51.1.15"},{"key":"2016011923145449000_14.2.257.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05429.x"},{"key":"2016011923145449000_14.2.257.6","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.488"},{"issue":"6D","key":"2016011923145449000_14.2.257.7","first-page":"4717","article-title":"The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer","volume":"17","author":"Strang","year":"1997","journal-title":"Anticancer Res"},{"key":"2016011923145449000_14.2.257.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.042"},{"key":"2016011923145449000_14.2.257.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.147"},{"key":"2016011923145449000_14.2.257.10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh141"},{"key":"2016011923145449000_14.2.257.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11701"},{"key":"2016011923145449000_14.2.257.12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20308"},{"key":"2016011923145449000_14.2.257.13","first-page":"129","article-title":"Pain assessment: Global use of the brief pain inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"2016011923145449000_14.2.257.14","first-page":"135","article-title":"NCCN practice guidelines for cancer pain","volume":"14","author":"Benedetti","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"2016011923145449000_14.2.257.15","unstructured":"Sutton AJ , Abrams KR , Jones DR , Sheldon TA , Song F . Methods for Meta-Analysis in Medical Research. Chichester: Wiley; 2000."},{"key":"2016011923145449000_14.2.257.16","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0074-5"},{"key":"2016011923145449000_14.2.257.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.05.026"},{"key":"2016011923145449000_14.2.257.18","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181651c0e"},{"key":"2016011923145449000_14.2.257.19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3816\/CGC.2007.n.022","article-title":"Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases cancer","volume":"6","author":"Saad","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"2016011923145449000_14.2.257.20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.urology.2007.03.071","article-title":"Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer","volume":"70","author":"Smith","year":"2007","journal-title":"Urology"},{"key":"2016011923145449000_14.2.257.21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3816\/CGC.2005.n.009","article-title":"Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate","volume":"1","author":"Saad","year":"2005","journal-title":"Clin Prostate Cancer"},{"key":"2016011923145449000_14.2.257.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.116"},{"key":"2016011923145449000_14.2.257.23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3816\/CLC.2004.n.030","article-title":"Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: Analysis based on history of skeletal complications","volume":"3","author":"Hirsh","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"2016011923145449000_14.2.257.24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11571"},{"key":"2016011923145449000_14.2.257.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.105"},{"key":"2016011923145449000_14.2.257.26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1540-0352(11)70118-4","article-title":"Zoledronic acid is effective in the treatment of prostate cancer patients with bone metastases","volume":"6","author":"Maung","year":"2002","journal-title":"Clin Prostate Cancer"},{"key":"2016011923145449000_14.2.257.27","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma","volume":"19","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2016011923145449000_14.2.257.28","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1012"},{"key":"2016011923145449000_14.2.257.29","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z"},{"key":"2016011923145449000_14.2.257.30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/clinchem\/39.4.614","article-title":"Increased urinary excretion of pyridinium cross-links in cancer patients","volume":"39","author":"Lipton","year":"1993","journal-title":"Clin Chem"},{"key":"2016011923145449000_14.2.257.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.05.009"},{"key":"2016011923145449000_14.2.257.32","doi-asserted-by":"crossref","unstructured":"Pavlakis N , Schmidt R , Stockler M . Bisphosphonates for breast cancer. Cochrane Database Syst Rev 2005;(3):CD003474.","DOI":"10.1002\/14651858.CD003474.pub2"},{"key":"2016011923145449000_14.2.257.33","doi-asserted-by":"crossref","unstructured":"Yuen KK , Shelley M , Sze WM , Wilt T , Mason MD . Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev 2006;(4):CD006250.","DOI":"10.1002\/14651858.CD006250"},{"key":"2016011923145449000_14.2.257.34","doi-asserted-by":"crossref","unstructured":"Djulbegovic B , Wheatley K , Ross J Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev 2002;(3):CD003188.","DOI":"10.1002\/14651858.CD003188"},{"key":"2016011923145449000_14.2.257.35","doi-asserted-by":"crossref","unstructured":"Wong RKS , Wiffen PJ . Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002;(2):CD002068.","DOI":"10.1002\/14651858.CD002068"},{"key":"2016011923145449000_14.2.257.36","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921050-00004"},{"key":"2016011923145449000_14.2.257.37","unstructured":"Zometa\u00ae (zoledronic acid) [summary of product characteristics]. West Sussex, UK: Novartis Europharm, Limited; 2003."},{"key":"2016011923145449000_14.2.257.38","unstructured":"European Medicines Agency. Scientific discussion [online]. 2005. Available from URL: http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/zometa\/021101en6.pdf (accessed 2007 Apr 4)."},{"key":"2016011923145449000_14.2.257.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.12.005"},{"key":"2016011923145449000_14.2.257.40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.02.032"},{"key":"2016011923145449000_14.2.257.41","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500574"},{"key":"2016011923145449000_14.2.257.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2007.00808.x"},{"key":"2016011923145449000_14.2.257.43","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-83668-8_6"},{"issue":"1","key":"2016011923145449000_14.2.257.44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)40597-0","article-title":"Palliation of painful bone metastases from prostate cancer using sodium etidronate: Results of a randomized, prospective, double-blind, placebo-controlled study","volume":"141","author":"Smith","year":"1989","journal-title":"J Urol"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/14\/2\/257\/5166684\/14-2-257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T13:48:21Z","timestamp":1595166501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1111\/pme.12016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/pme.12016"],"URL":"https:\/\/doi.org\/10.1111\/pme.12016","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}